⌘K

Login Start Free

Home/Filings/3/0001104659-25-103023

3//SEC Filing

NOVARTIS AG 3

Accession 0001104659-25-103023

$NVSCIK 0001827506other

View on SEC.gov Company Profile

Filed

Oct 27, 8:00 PM ET

Accepted

Oct 28, 12:12 PM ET

Size

4.5 KB

Accession

0001104659-25-103023

Insider Transaction Report

Form 3

Period: 2025-10-28

Tourmaline Bio, Inc.TRML

10% Owner

Holdings

Common Stock, par value $0.0001
(indirect: See Footnote)
24,030,382

Footnotes (1)

[F1]These shares are owned directly by Torino Merger Sub Inc., an indirect wholly-owned subsidiary of Novartis AG.

Documents

1 file

3
tm2529487-1_3seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Tourmaline Bio, Inc.

CIK 0001827506

Entity typeother

IncorporatedSwitzerland

Related Parties

1

filerCIK 0001114448

Filing Metadata

Form type: 3
Filed: Oct 27, 8:00 PM ET
Accepted: Oct 28, 12:12 PM ET
Size: 4.5 KB

View on SEC.gov